CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Cardiac monocytes and macrophages after myocardial infarction Universal Definition of Myocardial Infarction ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Successful catheter ablation of electrical storm after myocardial infarction Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia

Review Article2018 Dec;7(2):127-149.

JOURNAL:Cardiol Ther. Article Link

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review

Mohiaddin H, Wong TDFK, Burke-Gaffney A et al. Keywords: coronary artery disease; de novo; drug-coated balloon; drug-eluting balloon; percutaneous coronary intervention

FULL TEXT PDF